Easton Price To Sales Ratio vs Days Sales Outstanding Analysis

EAPH Stock  USD 0.0001  0.00  0.00%   
Easton Pharmaceutica financial indicator trend analysis is much more than just examining Easton Pharmaceutica latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Easton Pharmaceutica is a good investment. Please check the relationship between Easton Pharmaceutica Price To Sales Ratio and its Days Sales Outstanding accounts. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Easton Pharmaceutica. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.
For more detail on how to invest in Easton Stock please use our How to Invest in Easton Pharmaceutica guide.

Price To Sales Ratio vs Days Sales Outstanding

Price To Sales Ratio vs Days Sales Outstanding Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Easton Pharmaceutica Price To Sales Ratio account and Days Sales Outstanding. At this time, the significance of the direction appears to have significant contrarian relationship.
The correlation between Easton Pharmaceutica's Price To Sales Ratio and Days Sales Outstanding is -0.35. Overlapping area represents the amount of variation of Price To Sales Ratio that can explain the historical movement of Days Sales Outstanding in the same time period over historical financial statements of Easton Pharmaceutica, assuming nothing else is changed. The correlation between historical values of Easton Pharmaceutica's Price To Sales Ratio and Days Sales Outstanding is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Price To Sales Ratio of Easton Pharmaceutica are associated (or correlated) with its Days Sales Outstanding. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Days Sales Outstanding has no effect on the direction of Price To Sales Ratio i.e., Easton Pharmaceutica's Price To Sales Ratio and Days Sales Outstanding go up and down completely randomly.

Correlation Coefficient

-0.35
Relationship DirectionNegative 
Relationship StrengthInsignificant

Price To Sales Ratio

Price to Sales Ratio is figured by comparing Easton Pharmaceutica stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Easton Pharmaceutica sales, a figure that is much harder to manipulate than other Easton Pharmaceutica multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.

Days Sales Outstanding

Most indicators from Easton Pharmaceutica's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Easton Pharmaceutica current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Easton Pharmaceutica. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.
For more detail on how to invest in Easton Stock please use our How to Invest in Easton Pharmaceutica guide.The current Selling General Administrative is estimated to decrease to about 161.2 K. The current Discontinued Operations is estimated to decrease to about 966.1 K
 2016 2017 2023 2024 (projected)
Non Recurring119.2M113.4M102.1M93.4M
Discontinued Operations10.1M1.1M1.0M966.2K

Easton Pharmaceutica fundamental ratios Correlations

0.33-0.010.71-0.40.730.81-0.510.82-0.77-0.860.94-0.59-0.83-0.460.86-0.660.080.80.86-0.40.870.67-0.930.710.43
0.330.810.670.07-0.160.64-0.45-0.14-0.69-0.580.14-0.31-0.31-0.020.38-0.12-0.360.150.020.070.070.0-0.220.410.46
-0.010.810.15-0.03-0.160.21-0.39-0.31-0.55-0.41-0.1-0.110.010.22-0.090.02-0.18-0.09-0.16-0.03-0.14-0.20.06-0.01-0.02
0.710.670.15-0.050.10.81-0.450.35-0.6-0.630.53-0.45-0.6-0.380.76-0.34-0.350.490.4-0.050.420.43-0.590.750.73
-0.40.07-0.03-0.05-0.58-0.020.21-0.470.230.34-0.490.330.28-0.31-0.090.280.02-0.46-0.451.0-0.41-0.320.39-0.30.19
0.73-0.16-0.160.1-0.580.29-0.410.88-0.53-0.650.85-0.44-0.64-0.340.41-0.560.250.740.86-0.580.820.66-0.790.23-0.17
0.810.640.210.81-0.020.29-0.520.46-0.68-0.690.58-0.37-0.66-0.420.95-0.33-0.080.570.57-0.020.610.46-0.60.820.77
-0.51-0.45-0.39-0.450.21-0.41-0.52-0.520.660.7-0.440.120.670.47-0.43-0.090.23-0.74-0.650.21-0.64-0.780.43-0.24-0.08
0.82-0.14-0.310.35-0.470.880.46-0.52-0.49-0.640.87-0.36-0.66-0.540.61-0.510.240.780.91-0.470.870.83-0.810.430.11
-0.77-0.69-0.55-0.60.23-0.53-0.680.66-0.490.98-0.740.560.720.31-0.530.560.03-0.61-0.610.23-0.64-0.450.78-0.35-0.15
-0.86-0.58-0.41-0.630.34-0.65-0.690.7-0.640.98-0.850.60.80.37-0.590.590.01-0.74-0.740.34-0.75-0.590.87-0.41-0.15
0.940.14-0.10.53-0.490.850.58-0.440.87-0.74-0.85-0.63-0.79-0.410.66-0.750.170.780.87-0.490.870.67-0.980.490.15
-0.59-0.31-0.11-0.450.33-0.44-0.370.12-0.360.560.6-0.630.460.05-0.340.69-0.28-0.35-0.260.33-0.28-0.270.71-0.39-0.14
-0.83-0.310.01-0.60.28-0.64-0.660.67-0.660.720.8-0.790.460.49-0.680.280.2-0.95-0.840.28-0.88-0.770.81-0.41-0.18
-0.46-0.020.22-0.38-0.31-0.34-0.420.47-0.540.310.37-0.410.050.49-0.50.14-0.09-0.46-0.53-0.31-0.53-0.530.44-0.25-0.33
0.860.38-0.090.76-0.090.410.95-0.430.61-0.53-0.590.66-0.34-0.68-0.5-0.360.00.630.68-0.090.70.55-0.650.860.77
-0.66-0.120.02-0.340.28-0.56-0.33-0.09-0.510.560.59-0.750.690.280.14-0.36-0.41-0.19-0.390.28-0.38-0.10.77-0.34-0.12
0.08-0.36-0.18-0.350.020.25-0.080.230.240.030.010.17-0.280.2-0.090.0-0.41-0.160.030.020.04-0.05-0.14-0.05-0.12
0.80.15-0.090.49-0.460.740.57-0.740.78-0.61-0.740.78-0.35-0.95-0.460.63-0.19-0.160.92-0.460.930.88-0.760.40.09
0.860.02-0.160.4-0.450.860.57-0.650.91-0.61-0.740.87-0.26-0.84-0.530.68-0.390.030.92-0.450.990.83-0.810.420.11
-0.40.07-0.03-0.051.0-0.58-0.020.21-0.470.230.34-0.490.330.28-0.31-0.090.280.02-0.46-0.45-0.41-0.320.39-0.30.19
0.870.07-0.140.42-0.410.820.61-0.640.87-0.64-0.750.87-0.28-0.88-0.530.7-0.380.040.930.99-0.410.8-0.810.420.13
0.670.0-0.20.43-0.320.660.46-0.780.83-0.45-0.590.67-0.27-0.77-0.530.55-0.1-0.050.880.83-0.320.8-0.650.310.07
-0.93-0.220.06-0.590.39-0.79-0.60.43-0.810.780.87-0.980.710.810.44-0.650.77-0.14-0.76-0.810.39-0.81-0.65-0.47-0.17
0.710.41-0.010.75-0.30.230.82-0.240.43-0.35-0.410.49-0.39-0.41-0.250.86-0.34-0.050.40.42-0.30.420.31-0.470.87
0.430.46-0.020.730.19-0.170.77-0.080.11-0.15-0.150.15-0.14-0.18-0.330.77-0.12-0.120.090.110.190.130.07-0.170.87
Click cells to compare fundamentals

Easton Pharmaceutica Account Relationship Matchups

Easton Pharmaceutica fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets2.6M10.1M17.2M10.2M11.7M12.3M
Total Current Liabilities245.8K792.0K1.5M620.8K558.7K557.7K
Other Liab48.3K46.2K161.1K180.2K162.1K250.1K
Accounts Payable30.8K568.5K845.1K255.8K230.2K327.4K
Total Liab2.5M3.0M10.1M3.3M3.8M2.0M
Total Stockholder Equity160.0K7.1M7.1M6.9M7.9M8.3M
Other Assets1.8M742.6K95.8K94.0K84.6K80.4K
Net Tangible Assets(465.0K)(1.1M)(1.1M)(1.0M)(930.6K)(884.0K)
Retained Earnings(39.1M)(39.2M)(39.6M)(39.8M)(35.8M)(37.6M)
Long Term Debt2.2M2.2M8.5M2.5M2.9M1.9M
Total Current Assets198K66.3K249.8K426.3K383.7K234.0K
Long Term Investments926.6M1.1M1.7M1.7M1.6M1.5M

Currently Active Assets on Macroaxis

When determining whether Easton Pharmaceutica offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Easton Pharmaceutica's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Easton Pharmaceutica Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Easton Pharmaceutica Stock:
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Easton Pharmaceutica. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.
For more detail on how to invest in Easton Stock please use our How to Invest in Easton Pharmaceutica guide.
You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Easton Pharmaceutica. If investors know Easton will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Easton Pharmaceutica listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Revenue Per Share
0.001
Return On Assets
(0.01)
Return On Equity
(0.03)
The market value of Easton Pharmaceutica is measured differently than its book value, which is the value of Easton that is recorded on the company's balance sheet. Investors also form their own opinion of Easton Pharmaceutica's value that differs from its market value or its book value, called intrinsic value, which is Easton Pharmaceutica's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Easton Pharmaceutica's market value can be influenced by many factors that don't directly affect Easton Pharmaceutica's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Easton Pharmaceutica's value and its price as these two are different measures arrived at by different means. Investors typically determine if Easton Pharmaceutica is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Easton Pharmaceutica's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.